Astellas Pharma Inc.
4503 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町二丁目５番１号
- Website:
- https://www.astellas.com/en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Astellas Pharma Inc. is a global pharmaceutical company headquartered in Tokyo, Japan, dedicated to improving the health of patients through innovative medicines. Founded in 2005 from the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical, Astellas focuses on research and development in therapeutic areas such as oncology, urology, immunology, and neuroscience. The company emphasizes a patient-centric approach, striving to address unmet medical needs. Astellas operates in various markets worldwide and is committed to delivering high-quality healthcare solutions while adhering to strict ethical standards. With a robust pipeline of products under development, Astellas is poised to make significant contributions to global health.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Astellas Pharma Inc..
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-03 08:31 |
Regulatory News Service
訂正発行登録書
|
Japanese | 10.3 KB | |
| 2025-07-02 02:28 |
Regulatory News Service
臨時報告書
|
Japanese | 24.1 KB | |
| 2025-06-16 06:14 |
Regulatory News Service
内部統制報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 23.1 KB | |
| 2025-06-16 06:11 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-06-16 06:09 |
Annual Report
有価証券報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 2.5 MB | |
| 2025-02-04 07:47 |
Regulatory News Service
訂正発行登録書
|
Japanese | 9.9 KB | |
| 2025-02-04 07:40 |
Regulatory News Service
臨時報告書
|
Japanese | 19.4 KB | |
| 2025-02-04 07:39 |
Regulatory News Service
臨時報告書
|
Japanese | 20.9 KB | |
| 2024-11-06 05:52 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-06 05:51 |
Interim Report
半期報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 344.2 KB | |
| 2024-09-03 03:34 |
Regulatory News Service
発行登録追補書類（株券､社債券等）
|
Japanese | 96.0 KB | |
| 2024-07-19 04:20 |
Prospectus
発行登録書（株券､社債券等）
|
Japanese | 28.1 KB | |
| 2024-07-01 07:47 |
Regulatory News Service
臨時報告書
|
Japanese | 23.3 KB | |
| 2024-06-20 09:28 |
Regulatory News Service
内部統制報告書－第19期(2023/04/01－2024/03/31)
|
Japanese | 22.6 KB | |
| 2024-06-20 09:22 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB |
Automate Your Workflow. Get a real-time feed of all Astellas Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Astellas Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
